ISOLATION OF LYMPHOCYTE MEMBRANE COMPLEMENT RECEPTOR TYPE-2 (THE C3D RECEPTOR) AND PREPARATION OF RECEPTOR-SPECIFIC ANTIBODY
ISOLATION OF LYMPHOCYTE MEMBRANE COMPLEMENT RECEPTOR TYPE-2 (THE C3D RECEPTOR) AND PREPARATION OF RECEPTOR-SPECIFIC ANTIBODY
复制标题
DOI:
10.1073/pnas.78.3.1828
复制
发表时间:
1981-01-01
期刊:
影响因子:
--
通讯作者:
ROSS, GD
中科院分区:
文献类型:
--
作者:
LAMBRIS, JD;DOBSON, NJ;ROSS, GD
A glycoprotein binding complement component C3d was isolated from media used for culture of Raji human [Burkitt''s lymphoma] lymphoblastoid cells. Analysis by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and gas/liquid chromatography indicated that the C3d-binding glycoprotein consisted of a single polypeptide chain with extensive intrachain disulfide bonds, a MW of 72,000 and several different bound carbohydrates. This medium-derived C3d-binding protein apparently originated from membrane complement receptor type 2 (CR2, the C3d receptor), presumably shed during membrane turnover. The C3d-binding protein bound to sheep erythrocytes coated with C3d (EC3d) but not to sheep erythrocytes coated with C3b (EC3b). Antisera, prepared by immunization with the purified C3d-binding glycoprotein, inhibited lymphocyte rosette formation with EC3d but not with EC3b. Analysis by sodium dodecyl electrophoresis of the radiolabeled and solubilized lymphocyte antigens reactive with the anti-C3d-binding protein sera revealed a single-chain cell-surface protein of MW 72,000 that was apparently identical to the isolated C3d-binding protein. Parallel assay of lymphocytes for CR2 by direct immunofluorescence with F(ab'')2 anti-C3d-binding protein (anti-CR2) and rosette formation with EC3d indicated that both assays had the same specificity and nearly the same sensitivity. With both systems CR2 expression was limited to B cells and was undetectable on T cells, monocytes or neutrophils.